Collegium Pharmaceutical Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$159,301	$145,276	$144,923	$149,745
Gross Profit	96,794	90,806	91,456	94,630
EBITDA	75,721	80,151	89,395	101,454
EBIT	33,974	44,684	53,961	65,991
Net Income	9,335	19,606	27,713	31,940
Net Change In Cash	159,301	145,276	144,923	149,745
Free Cash Flow	-9,243	67,128	61,369	73,174
Cash	38,960	172,894	228,610	238,947
Basic Shares	40,163	40,383	41,438	41,788

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$566,767	$463,933	$276,868	$310,016
Gross Profit	326,169	209,488	150,617	179,836
EBITDA	308,328	168,757	86,575	118,071
EBIT	159,072	34,366	17,640	56,464
Net Income	48,155	-25,002	71,517	26,752
Net Change In Cash	566,767	463,933	276,868	310,016
Cost of Revenue		-12,738	12,310	6,644
Free Cash Flow	274,288	122,608	101,613	-279,830
Cash	238,947	173,688	186,426	174,116
Basic Shares	41,788	33,829	41,045	35,151